SCHEMBL5673255

SCHEMBL5673255

Cc1ccccc1-c1nc(N)nc2c1nc(N)n2-c1ccccc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.47
▸ EPHB4 P54760 2/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.40
▸ HEXA P06865 1/20 0.39
▸ HEXB P07686 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ DHFR P00374 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PI4K2B Q8TCG2 1/20 0.35
▸ PI4K2A Q9BTU6 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35
▸ DPP4 P27487 2/20 0.34
▸ ADORA3 P0DMS8 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ PKMYT1 Q99640 2/20 0.33
▸ LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426848 0.70 HCAR1 (0.49) EPHB4HCAR1TSHRPI4KAPI4K2B
SCHEMBL425837 0.67 MEN1 (0.44) ADORA2ATP53TSHRDHFRPI4KA
SCHEMBL4106568 0.65 ADORA2A (0.57) ADORA2AHEXAHEXBHSP90AA1DHFR
SCHEMBL2194828 0.65 HCAR1 (0.52) EPHB4HCAR1TP53TSHRPIK3CD
SCHEMBL1553505 0.64 HCAR1 (0.48) EPHB4HCAR1LMNAALDH1A1L3MBTL1
SCHEMBL24309389 0.64 ADORA2A (0.57) ADORA2AHEXAHEXBHSP90AA1DHFR
SCHEMBL27310325 0.64 ADORA2A (1.00) ADORA2ADHFRALDH1A1
Ammonia Solution, Strong SCHEMBL6723599 0.64 ADORA2A (0.49) ADORA2AHEXAHEXBHSP90AA1DHFR
SCHEMBL3425059 0.63 ADORA2A (0.56) ADORA2AHEXAHEXBHSP90AA1DHFR
SCHEMBL5528139 0.62 HCAR1 (0.43) EPHB4HCAR1TP53TSHRPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556140-A4 NOVEL COMPOUNDS SYNTA PHARMACEUTICALS CORP (US) 2006-04-19 — — EP disclosed
EP-1626725-A2 HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS Synta Pharmaceuticals Corporation (US) 2006-02-22 — — EP disclosed
EP-1556140-A2 NOVEL COMPOUNDS Synta Pharmaceuticals Corporation (US) 2005-07-27 — — EP disclosed
WO-2005000404-A2 HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS SYNTA PHARMACEUTICALS, CORP. (US) 2005-01-06 — — WO disclosed
WO-2004035740-A2 AROMATIC BICYCLIC HETEROCYLES TO MODULATE 1L - 12 PRODUCTION SYNTA PHARMACEUTICALS CORP. (US) 2004-04-29 — — WO disclosed
Send feedback